Macromolecule Analysis Employing Nucleic Acid Encoding
2026 DF Peptide Acquisition LLC
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 6 of these applications claim priority to application PCT/US2017/030702, filed May 2, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,959,922 | Macromolecule Analysis Employing Nucleic Acid Encoding In force · High confidence UsedRemaining | 2026 DF Peptide Acquisition LLC | In force | High confidence | ||
| US 12,019,077 | Macromolecule Analysis Employing Nucleic Acid Encoding In force · High confidence | 2026 DF Peptide Acquisition LLC | In force | High confidence | ||
| US 12,019,078 | Macromolecule Analysis Employing Nucleic Acid Encoding In force · Medium confidence | 2026 DF Peptide Acquisition LLC | In force | Medium confidence | ||
| US 12,235,276 | Macromolecule Analysis Employing Nucleic Acid Encoding In force · Medium confidence | 2026 DF Peptide Acquisition LLC | In force | Medium confidence | ||
| US 12,517,133 | Macromolecule Analysis Employing Nucleic Acid Encoding In force · Medium confidence | 2026 DF Peptide Acquisition LLC | In force | Medium confidence | ||
| US 12,123,878 | Macromolecule Analysis Employing Nucleic Acid Encoding In force · Medium confidence | 2026 DF Peptide Acquisition LLC | In force | Medium confidence | ||
| Application 18/659,813 | Macromolecule Analysis Employing Nucleic Acid Encoding Pending Not granted | 2026 DF Peptide Acquisition LLC | Pending | Not granted |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by 2026 DF Peptide Acquisition LLC.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.